SCHEMBL22144673

SCHEMBL22144673

O=C1CCN(c2ccc(N3CCCCC3)cc2)C(=O)N1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 6/20 0.67
DDB1 Q16531 5/20 0.67
ALDH1A1 P00352 5/20 0.47
LMNA P02545 1/20 0.47
HSP90AA1 P07900 1/20 0.47
CCR6 P51684 1/20 0.47
CACNA1B Q00975 1/20 0.47
APBA1 Q02410 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 3/20 0.47
MAPT P10636 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.47
TP53 P04637 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30969021 0.98 CRBN (0.65) CRBNDDB1ALDH1A1LMNAHSP90AA1
SCHEMBL22119794 0.85 CRBN (0.65) CRBNDDB1ALDH1A1LMNAKDM4E
SCHEMBL25634636 0.83 CRBN (0.63) CRBNDDB1ALDH1A1LMNAKDM4E
Hydrochloric Acid SCHEMBL22119617 0.83 CRBN (0.63) CRBNDDB1ALDH1A1LMNAKDM4E
SCHEMBL31447730 0.82 DDB1 (0.50) CRBNDDB1MAPTTP53L3MBTL1
SCHEMBL25193821 0.81 DDB1 (0.49) CRBNDDB1ALDH1A1TDP1KDM4E
SCHEMBL24955690 0.81 CRBN (0.61) CRBNDDB1ALDH1A1KDM4EPTGS2
SCHEMBL25170633 0.81 CRBN (0.59) CRBNDDB1ALDH1A1KDM4EL3MBTL1
SCHEMBL22119568 0.81 CRBN (0.64) CRBNDDB1ALDH1A1KDM4EL3MBTL1
SCHEMBL27039647 0.80 CRBN (1.00) CRBNDDB1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024227104-A1 BIFUNCTIONAL COMPOUNDS FOR DEGRADING BRAF VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2024-10-31 WO disclosed
EP-4430052-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF Nurix Therapeutics, Inc. (US) 2024-09-18 EP disclosed
CN-116589466-A Degradation of Bruton's Tyrosine Kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligands and methods of use thereof 百济神州有限公司 2023-08-15 CN disclosed
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 WO disclosed
WO-2020132561-A1 TARGETED PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2020-06-25 WO disclosed